oldar.ru


Cara Therapeutics Stock Price

Research Cara Therapeutics' (Nasdaq:CARA) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and. Cara Therapeutics Inc ; Previous Close: ; Open: ; Volume: , ; 3 Month Average Trading Volume: ; Shares Out (Mil): CARA Related stocks ; Cara Therapeutics ; AMGN, , +% ; Amgen Inc ; VRTX, , +%. View the CARA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cara Therapeutic real. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. CARA will report earnings.

Overview · Interactive Chart · Company Vitals. XNAS: CARA. price (usd). (%). daily change. 52 week low. 52 week high. 1Y5Y10YMax. Clearside Biomedical Inc. $ CLSD % ; Outlook Therapeutics Inc. $ OTLK % ; Stoke Therapeutics Inc. $ STOK % ; CareCloud Inc. $ CCLD. Cara Therapeutics Inc CARA:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date08/30/23 · 52 Week Low Cara Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CARA updated stock price target summary. On average, Wall Street analysts predict that Cara Therapeutics's share price could reach $ by Jun 13, The average Cara Therapeutics stock price. CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to. Discover real-time Cara Therapeutics, Inc. Common Stock (CARA) stock prices, quotes, historical data, news, and Insights for informed trading and investment. (NASDAQ: CARA) Cara Therapeutics currently has 54,, outstanding shares. With Cara Therapeutics stock trading at $ per share, the total value of Cara. Check if CARA Stock has a Buy or Sell Evaluation. CARA Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Cara Therapeutics News. View Cara Therapeutics Inc CARA stock quote prices, financial information, real-time forecasts, and company news from CNN. Based on analysts offering 12 month price targets for CARA in the last 3 months. The average price target is $1 with a high estimate of $1 and a low.

Cara Therapeutics traded at $ this Tuesday April 9th, increasing $ or percent since the previous trading session. Looking back, over the last four. Stock Quote ; Change. (%) ; Volume. , ; Today's Open. $ ; Previous Close. $ Cara Therapeutics Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - Cara Therapeutics (CARA) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the last. (NasdaqCM) - Forecast, Price Target, Estimates, Predictions. Cara Therapeutics, Inc. NasdaqCM. The current price of CARA is USD — it has decreased by −% in the past 24 hours. Watch Cara Therapeutics, Inc. stock price performance more closely. On Friday 08/30/ the closing price of the Cara Therapeutics Inc share was $ on BTT. Compared to the opening price on Friday 08/30/ on BTT of $ Stock analysis for Cara Therapeutics Inc (CARA:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company.

CARA Related stocks ; Cara Therapeutics ; AMGN, , +% ; Amgen Inc ; VRTX, , +%. Cara Therapeutics Inc. · · Partner Center · Your Watchlists · Recently Viewed Tickers · CARA Overview · Key Data · Performance · Analyst Ratings. Sell. The 2 analysts with month price forecasts for Cara Therapeutics stock have an average target of , which predicts an increase of % from the current. See the latest Cara Therapeutics Inc stock price (CARA:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Cara Therapeutics (CARA) reported Q2 earnings per share (EPS) of -$, missing estimates of -$ by %. In the same quarter last year, Cara.

Stock price for similar companies or competitors ; Cara Therapeutics Logo. AcelRx Pharmaceuticals. ACRX. $, %, USA ; Cara Therapeutics Logo. Pfizer. Cara Therapeutics Inc ; Jun, Reiterated, H.C. Wainwright, Buy, $24 → $26 ; Mar, Resumed, H.C. Wainwright, Buy, $ Get the latest Cara Therapeutics Inc. (CARA) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. How much percentage Cara Therapeutics Inc is up from its 52 Week low? Cara Therapeutics Inc (CARA) share price is $ It is up by 1% from its 52 Week Low.

Best Paying Legit Survey Sites | What Foundation Does Not Look Cakey

20 21 22 23 24

Copyright 2016-2024 Privice Policy Contacts SiteMap RSS